Insider · CIK 0001664801
Albert D. Dyrness
Files at SONN (Sonnet BioTherapeutics Holdings, Inc.), PURR (Hyperliquid Strategies Inc). First filing -, latest -.
Albert D. Dyrness files SEC Form 4 as director at SONN (Sonnet BioTherapeutics Holdings, Inc.), and also at PURR (Hyperliquid Strategies Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Albert D. Dyrness has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | PURR Hyperliquid Strategies Inc | AGrant or award Common Stock | +40,789 | $0.00 | $0 | 41,671 | Feb 11, 2026 |
| Dec 2, 2025 | PURR Hyperliquid Strategies Inc | JOther Common Stock | +882 | - | - | 882 | Dec 23, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | DDisposition to issuer Common Stock | -4,537 | - | - | 0 | Dec 3, 2025 |
| Jul 11, 2023 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +4,000 | - | - | 4,537 | Jul 15, 2025 |
| Dec 11, 2023 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +373 | - | - | 537 | Dec 5, 2024 |
Questions about Albert D. Dyrness
Answered from the filings on this page, as of the latest one.
Is Albert D. Dyrness buying or selling?
Albert D. Dyrness has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Albert D. Dyrness's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Albert D. Dyrness has 0.
Where does Albert D. Dyrness file Form 4?
Albert D. Dyrness has filed Form 4 at SONN (Sonnet BioTherapeutics Holdings, Inc.); PURR (Hyperliquid Strategies Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.